| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.3 | 0.1 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.21 | 0.3 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.02 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.009 |